Allecra receives upfront, development and commercial milestone payments, in addition to double-digit royalties ADVANZ gains commercial rights for cefepime/enmetazobactam in the European Union, the ...
The U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) will collaborate with the U.S. Department of Defense’s Defense Threat Reduction ...
June 29, 2007 — The US Food and Drug Administration (FDA) has approved first-time generic formulations for cefepime hydrochloride 500 mg, 1 g, and 2 g base/vial for parenteral administration in the ...
For bloodstream infections caused by chromosomal AmpC β-lactamase-producing strains, cefepime may be an appropriate carbapenem-sparing treatment option. Cefepime is supported as an alternative to ...
SAINT-LOUIS, France & WEILL AM RHEIN, Germany--(BUSINESS WIRE)--Allecra Therapeutics (“Allecra”), a biopharmaceutical company developing novel therapies to combat antibiotic resistance, announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results